natgillin/translations-raw huggingface dataset:
Article 41(1)(d) and (e)
Člen 42(1)(d) in (e)
Article 41(1)(f)
Člen 42(1)(f)
Article 10 fourth indent
Četrta alinea člena 10
Annex I(1) to (4)
Priloga I(1) do (4)
Annex I(4) last paragraph
Zadnji pododstavek Priloge I(4)
Article 2(22)
Člen 2(22)
Annex I(5) to (7)
Priloga I(5) do (7)
Annex I(8)
Priloga I(8)
Annex I(9) to (11)
Priloga I(9) do (11)
Annex I(8) to (10)
Priloga I(8) do (10)
Annex I(12) to (14)
Priloga I(12) do (14)
Annex I(15) and (16)
Priloga I(15) in (16)
Article 2(12)
Člen 2(12)
Annex I(17) to (41)
Priloga I(17) do (41)
Annex I(15) to (39)
Priloga I(15) do (39)
Annex I(42) to (56)
Priloga I(42) do (56)
Annex II(1) and (2)
Priloga II(1) in (2)
Annex II(3) to (10)
Priloga II(3) do (11)
Annex III(1)
Priloga III(1)
Annex III(1) first sub-paragraph
Prvi pododstavek Priloge III(1)
Article 1(7) and Annex 3(a)
Člen 1(7) in Priloga 3(a)
Annex III(2)
Priloga III(2)
Annex III(2.1) first to third paragraphs
Prvi do tretji pododstavek Priloge III(2.1)
Annex III(3.1)
Priloga III(3.1)
Article 1(7) and Annex 3(b)
Člen 1(7) in Priloga 3(b)
Annex III(2.1) fourth paragraph
Četrti pododstavek Priloge III(2.1)
Annex III(2.1) fifth paragraph
Peti pododstavek Priloge III(2.1)
Annex III(3.2)
Priloga III(3.2)
Annex III(2.2), (3), (3.1)
Priloga III(2.2), (3), (3.1)
Annex III(4) to (6)
Priloga III(4) do (6)
Article 1(7) and Annex 3(c)
Člen 1(7) in Priloga 3(c)
Annex III(8)
Priloga III(8)
Annex III(4)
Priloga III(4)
Annex III(11)
Priloga III(11)
Annex IV(1) to (20)
Priloga IV(1) do (20)
Annex VII(1) to (20)
Priloga VII(1) do (20)
Article 1(7) and Annex 5
Člen 1(7) in Priloga 5
Annex IV(21)
Priloga IV(21)
Article 11a
Člen 11a
Article 1(6)
Člen 1(6)
Annex V(1) to (12) fourth paragraph
Četrti pododstavek Priloge V(1) do (12)
Annex VIII(1) to (13)(ii)
Priloga VIII(1) do (13)(ii)
Annex V(12) fifth paragraph
Priloga V(12) peti pododstavek
Annex V(12) sixth paragraph to (13)
Priloga V(12) šesti pododstavek k (13)
Annex VIII(13)(iii) to (14)
Priloga VIII(13)(iii) do (14)
Annex VI(8)(2) after the first sentence
Priloga VI(8)(2) po prvem stavku
Acting on a proposal from the Commission and in accordance with the procedure laid down in Article 251 of the Treaty, the Parliament and the Council may renew those provisions and, to that end, shall review them prior to the expiry of the period or by the date referred to in this paragraph, whichever the earlier.
Na predlog Komisije lahko Evropski parlament in Svet obnovita zadevne določbe v skladu s postopkom, določenim v členu 251 Pogodbe, in jih v ta namen pregledata pred iztekom v tem odstavku navedenega obdobja ali dneva.
The Committee shall adopt its Rules of Procedure
Odbor sprejme svoj poslovnik.
TREATMENT OF THE PROTECTION BUYER
OBRAVNAVA KUPCA ZAVAROVANJA
For the party who transfers credit risk (the ‘protection buyer’), the positions are determined as the mirror image of the protection seller, with the exception of a credit linked note (which entails no short position in the issuer).
Za stranko, ki prenese kreditno tveganje („kupec zavarovanja“), se pozicije določijo kot zrcalna slika prodajalca zavarovanja, z izjemo kreditnega zapisa (ki ne ustvari kratke pozicije v obveznosti izdajatelja).
If at a given moment there is a call option in combination with a step‐up, such moment is treated as the maturity of the protection.
Če v danem trenutku obstaja prodajna opcija v kombinaciji s stopnjevanjem, se tak trenutek obravnava kot zapadlost zavarovanja.
In the case of nth to default credit derivatives, protection buyers are allowed to off‐set specific risk for n-1 of the underlyings (i.e., the n-1 assets with the lowest specific risk charge).
V primeru kreditnih izvedenih finančnih instrumentov na podlagi n-tega neplačila, je kupcem zavarovanja dovoljeno, da izravnajo posebno tveganje za n-1 osnovnih sredstev (tj. n-1 sredstev z najnižjo zahtevo za posebno tveganje).
One
Ena
Marking to market is the at least daily valuation of positions at readily available close out prices that are sourced independently. Examples include exchange prices, screen prices, or quotes from several independent reputable brokers.
Vrednotenje na podlagi tekočih tržnih cen pomeni vsaj dnevno vrednotenje pozicij po dostopnih realiziranih cenah, pridobljenih od neodvisnih virov kot so na primer: borzne cene, elektronske kotacije ali kotacije več neodvisnih uglednih borznih posrednikov.
The sum of the two figures shall be its overall gross position. The difference between them shall be its overall net position.
Razlika med vrednostjo vseh neto dolgih in vrednostjo vseh neto kratkih pozicij je skupna neto pozicija v lastniških finančnih instrumentih.
Borrell Fontelles
Borell fontelles
Article 41(1)(g) Article 42
Člen 42(1)(g)
D = Σt=1
D = ((Σt = 1
Zone Maturity band
Skupina razredov zapadlosti
t Ct
((t Ct)
Commission Directive 2006/50/EC
Direktiva Komisije 2006/50/ES
amending Annexes IVA and IVB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market
o spremembi prilog IVA in IVB Direktive 98/8/ES Evropskega parlamenta in Sveta o dajanju biocidnih pripravkov v promet
Having regard to Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market [1], and in particular Article 29 thereof,
ob upoštevanju Direktive 98/8/ES Evropskega parlamenta in Sveta z dne 16. februarja 1998 o dajanju biocidnih pripravkov v promet [1], in zlasti člena 29 Direktive,
Annexes IVA and IVB to Directive 98/8/EC set out the requirements for the dossiers to be submitted by applicants for, respectively, inclusion of an active substance consisting of micro-organisms including viruses and fungi in Annex I or IA to that Directive, and authorisation of a biocidal product based on preparations of such micro-organisms including viruses and fungi.
Prilogi IVA in IVB k Direktivi 98/8/ES določata zahteve za dokumentacijo, ki jo vlagatelj predloži za vključitev aktivne snovi, ki vsebuje mikroorganizme, vključno z virusi in glivami, v Prilogo I ali IA k navedeni direktivi, in za izdajo dovoljenja za biocidni pripravek na podlagi pripravkov iz teh mikroorganizmov, vključno z virusi in glivami.
It is necessary to adapt Annexes IVA and IVB to Directive 98/8/EC to technical progress and to developments in related legislation, in particular Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market [2] and Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the environment of genetically modified organisms [3], in order to provide a better basis for carrying out the risk assessments for micro-organisms and the biocidal products containing them.
Da bi zagotovili boljšo podlago za izvajanje ocene tveganja za mikroorganizme in biocidne pripravke, ki jih vsebujejo, je treba prilagoditi Prilogi IVA in IVB k Direktivi 98/8/ES tehničnemu napredku in razvoju tozadevne zakonodaje, zlasti Direktivi Sveta 91/414/EGS z dne 15. julija 1991 o dajanju fitofarmacevtskih sredstev v promet [2] in Direktivi 2001/18/ES Evropskega parlamenta in Sveta z dne 12. marca 2001 o namernem sproščanju gensko spremenjenih organizmov v okolje [3].
In addition, there have been scientific and technical developments within the field of microbiology and biotechnology.
Nadalje je bil dosežen znanstveni in tehnični napredek na področju mikrobiologije in biotehnologije.
Providing for a similar structure of the data requirements in the framework of Directive 98/8/EC with those of Directive 91/414/EEC will facilitate the work of applicants submitting dossiers within both legal frameworks and the work of the Member States authorities evaluating such dossiers.
Določitev podobne sestave zahtev za podatke v okviru Direktive 98/8/ES kot je v Direktivi 91/414/EGS bo olajšala delo vlagateljem pri vložitvi dokumentacije za oba pravna okvira ter delo organov držav članic, ki to dokumentacijo ocenjujejo.
It is therefore appropriate to update the data requirements for micro-organisms including viruses and fungi currently contained in Directive 98/8/EC and to align them as far as possible with those established in the framework of Directive 91/414/EEC.
Zato je primerno, da se zahteve za podatke za mikroorganizme, vključno z virusi in glivami, ki so trenutno v Direktivi 98/8/ES, posodobijo in se kar najbolj prilagodijo tistim iz Direktive 91/414/EGS.
The measures provided for in this Directive are in accordance with the opinion of the Standing Committee on Biocidal Products.
Ukrepi, predvideni s to direktivo, so v skladu z mnenjem Stalnega odbora za biocidne pripravke –
Annexes IVA and IVB to Directive 98/8/EC are replaced by the text set out in the Annex to this Directive.
Prilogi IVA in IVB k Direktivi 98/8/ES se nadomestita z besedilom iz Priloge k tej direktivi.
Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 1 January 2008 at the latest.
Države članice sprejmejo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 1. januarja 2008.
They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.
Besedilo teh predpisov, skupaj s korelacijsko tabelo med predloženimi predpisi in to direktivo, nemudoma pošljejo Komisiji.
When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication.
Ko države članice sprejmejo navedene predpise, morajo ti vsebovati sklic na to direktivo ali pa morajo biti s sklicem opremljeni ob uradni objavi.
Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive.
Države članice pošljejo Komisiji besedilo temeljnih predpisov nacionalne zakonodaje, sprejetih na področju, ki ga pokriva ta direktiva.
ANNEX IVA
PRILOGA IVA
DATA SET FOR ACTIVE SUBSTANCES
PODATKI ZA AKTIVNE SNOVI
MICRO-ORGANISMS INCLUDING VIRUSES AND FUNGI
MIKROORGANIZMI, VKLJUČNO Z VIRUSI IN GLIVAMI
For the purposes of this Annex, the term micro-organisms shall be understood as including also viruses and fungi.
Za namene te priloge izraz mikroorganizmi vključuje tudi viruse in glive.
Dossiers on active micro-organisms shall address at least all the points listed under “Dossier requirements” below.
V dokumentaciji o aktivnih mikroorganizmih morajo biti zajete najmanj vse točke, ki so navedene v ‚Zahtevah glede dokumentacije‘ spodaj.
For all micro-organisms subject to an application for inclusion into Annex I or IA, all available relevant knowledge and information in literature must be provided.
Za vse mikroorganizme, za katere se vloži zahtevek za vključitev v Prilogo I ali IA, je treba predložiti vsa razpoložljiva ustrezna dognanja in informacije iz literature.
The information related to the identification and characterisation of a micro-organism including mode of action is particularly important and must be entered in sections I to IV and provides the basis for an assessment of potential impacts on human health and of environmental effects.
Informacije glede odkrivanja in opredelitve mikroorganizma, vključno z načinom delovanja, so posebej pomembne in jih je treba vnesti v oddelke I do IV in opredeljujejo osnovo za oceno možnih vplivov na zdravje ljudi in učinkov na okolje.
Where information is not necessary owing to the nature of the micro-organism Article 8(5) shall apply.
Če podatki zaradi narave mikroorganizma niso potrebni, se uporablja člen 8(5).
A dossier within the meaning of Article 11(1) shall be prepared on strain level of the micro-organism unless information is submitted that shows that the species is known to be sufficiently homogeneous regarding all characteristics, or the applicant provides other arguments in accordance with Article 8(5).
Treba je pripraviti dokumentacijo v smislu člena 11(1) o ravni sevov mikroorganizma, razen če se predloži informacije, ki kažejo, da je vrsta znana kot dovolj homogena glede vseh značilnosti, ali če vlagatelj zagotovi druga dokazila v skladu s členom 8(5).
Where the micro-organism has been genetically modified within the meaning of Article 2(2) of Directive 2001/18/EC, a copy of the evaluation of the data concerning the assessment of the risks to the environment as established in Article 4(2) of that Directive, shall also be submitted.
Če je mikroorganizem gensko spremenjen v smislu člena 2(2) Direktive 2001/18/ES, je treba predložiti tudi kopijo ocene podatkov z oceno tveganja za okolje, kakor je določeno v členu 4(2) navedene direktive.
If the biocidal product action is known to be partly or entirely due to the effect of a toxin/metabolite, or if significant residues of toxins/metabolites are to be expected not related to the effect of the active micro-organism, a dossier for the toxin/metabolite shall be submitted in accordance with the requirements of Annexes IIA and, where specified, the relevant parts of Annex IIIA.
Če je znano, da je učinek biocidnega proizvoda delno ali v celoti posledica delovanja toksina/metabolita, ali se pričakujejo znatni ostanki toksinov/metabolitov, ki niso povezani z učinkovanjem mikroorganizma, je treba za toksin/metabolit predložiti dokumentacijo v skladu z zahtevami Priloge IIA in, če je posebej določeno, zadevnih delov Priloge IIIA.
Dossier requirements
Zahteve glede dokumentacije
SECTIONS:
ODDELKI:
I. Identity of the micro-organism
I. Opis mikroorganizma
Biological properties of the micro-organism
Biološke lastnosti mikroorganizma
Further information on the micro-organism
Dodatne informacije o mikroorganizmu
Analytical methods
Analizne metode
V. Effects on human health
V. Vplivi na zdravje ljudi
Residues in or on treated materials, food and feed
Ostanki v ali na tretiranih snoveh, hrani in krmi
Fate and behaviour in the environment
Končno stanje in obnašanje v okolju
Effects on non-target organisms
Vplivi na neciljne organizme
Classification and labelling
Razvrščanje in označevanje
Summary and evaluation of sections I to IX including conclusions of the risk assessment and recommendations
Povzetek in ocena oddelkov I do IX, vključno z zaključki ocene tveganja in priporočili
The following data will be required to support submissions on the above points.
Dokumentaciji je treba priložiti naslednje podatke v zvezi z zgoraj navedenimi točkami.
I. IDENTITY OF THE MICRO-ORGANISM
I. OPREDELITEV MIKROORGANIZMA
Name and species description, strain characterisation
Ime in opis vrste, karakterizacija seva
Common name of the micro-organism (including alternative and superseded names)
Splošno ime mikroorganizma (tudi druga in prej veljavna imena)
Taxonomic name and strain indicating whether it is a stock variant, a mutant strain or a genetically modified organism (GMO); for viruses, taxonomic designation of the agent, serotype, strain or mutant
Taksonomska oznaka in sev, ki pove, ali gre za izhodiščni sev, mutantni sev ali gensko spremenjeni organizem (GSO); pri virusih: taksonomska oznaka organizma, serotip, sev ali mutant
Collection and culture reference number where the culture is deposited
Zbirka in referenčna številka kulture, če je ta shranjena
Methods, procedures and criteria used to establish the presence and identity of the micro-organism (e.g. morphology, biochemistry, serology, etc.)
Metode, postopki in merila za ugotavljanje prisotnosti in opis mikroorganizma (na primer morfologija, biokemija, serologija, itd.)
Specification of the material used for manufacturing of formulated products
Specifikacija snovi, uporabljene za proizvodnjo formuliranih proizvodov
Content of the micro-organism
Vsebina mikroorganizma
Identity and content of impurities, additives, contaminating micro-organisms
Identiteta in vsebnost nečistoč, dodatkov, kontaminantnih mikroorganizmov
Analytical profile of batches
Analitske lastnosti partij
BIOLOGICAL PROPERTIES OF THE MICRO-ORGANISM
BIOLOŠKE LASTNOSTI MIKROORGANIZMA
History of the micro-organism and its uses.
Zgodovina mikroorganizma in njegovih uporab.
Natural occurrence and geographical distribution
Naravna navzočnost in geografska razširjenost
Historical background
Zgodovinsko ozadje
Origin and natural occurrence
Izvor in naravna navzočnost
Information on target organism(s)
Informacije o ciljnem(-ih) organizmu(-ih)
Description of the target organism(s)
Opis ciljnega(-ih) organizma(-ov)
Mode of action
Način delovanja
Host specificity range and effects on species other than the target organism
Razpon specifičnih gostiteljev in vplivi na vrste, ki niso ciljni organizmi
Development stages/life cycle of the micro-organism
Razvojne faze/življenjski ciklus mikroorganizma
Infectiveness, dispersal and colonisation ability
Kužnost, širjenje in sposobnost koloniziranja
Relationships to known plant or animal or human pathogens
Razmerja z znanimi rastlinskimi, živalskimi ali človeškimi patogeni
Genetic stability and factors affecting it
Genska stabilnost in dejavniki, ki vplivajo nanjo
Information on the production of metabolites (especially toxins)
Informacije o tvorjenju metabolitov (zlasti toksinov)
Antibiotics and other anti-microbial agents
Antibiotiki in druga antimikrobiološka sredstva
Robustness to environmental factors
Stabilnost pri okoljskih dejavnikih
Effects on materials, substances and products
Vplivi na materiale, snovi in proizvode
FURTHER INFORMATION ON THE MICRO-ORGANISM
NADALJNJE INFORMACIJE O MIKROORGANIZMU
Field of use envisaged
Predvideno področje uporabe
Product type(s) and category of users for which the micro-organism should be listed in Annex I, IA or IB
Tip(i) proizvoda in kategorije uporabnikov, za katere je mikroorganizme treba uvrstiti v Prilogi I, IA ali IB
Method of production and quality control
Proizvodni postopek in obvladovanje kakovosti
Information on the occurrence or possible occurrence of the development of resistance of the target organism(s)
Informacije o pojavu ali možnem pojavu razvoja odpornosti ciljnega(-ih) organizma(-ov)
Methods to prevent loss of virulence of seed stock of the micro-organism
Postopki preprečevanja izgube virulence izvorne kulture mikroorganizma
Recommended methods and precautions concerning handling, storage, transport or fire
Priporočene metode in varnostni ukrepi v zvezi z rokovanjem, skladiščenjem, prevozom ali požarom
Procedures for destruction or decontamination
Postopki uničenja ali dekontaminacije
Measures in case of an accident
Ukrepi v primeru nesreče
Procedures for waste management
Postopki za ravnanje z odpadki
Monitoring plan to be used for the active micro-organism including handling, storage, transport and use
Načrt spremljanja, ki se uporabi za aktivne mikroorganizme, vključno z rokovanjem, shranjevanjem, prevozom in uporabo
ANALYTICAL METHODS
ANALIZNI POSTOPKI
Methods for the analysis of the micro-organism as manufactured
Metode analiz mikroorganizma, kakor se proizvaja
Methods to determine and quantify residues (viable or non-viable)
Metode za določitev in količinsko opredeljevanje ostankov (živih ali ne-živih)
V. EFFECTS ON HUMAN HEALTH
V. VPLIVI NA ZDRAVJE LJUDI
TIER I
STOPNJA I
Basic information
Osnovne informacije
Medical data
Zdravstveni podatki
Medical surveillance on manufacturing plant personnel
Zdravstveni nadzor delavcev v proizvodnih obratih
Sensitisation/allergenicity observations
Ugotovitve o občutljivosti/alergenosti
Direct observation, e.g. clinical cases
Neposredna opazovanja, npr. klinični primeri
Basic studies
Osnovne raziskave
Sensitisation
Preobčutljivost (senzibilizacija)
Acute toxicity, pathogenicity, and infectiveness
Akutna toksičnost, patogenost in kužnost
Acute oral toxicity, pathogenicity and infectiveness
Akutna oralna toksičnost, patogenost in kužnost
Acute inhalation toxicity, pathogenicity and infectiveness
Akutna toksičnost pri vdihavanju, patogenost in kužnost
Intraperitoneal/subcutaneous single dose
Enkratni intraperitonealni/subkutani odmerek
In vitro genotoxicity testing
Preskušanje genotoksičnosti in vitro
Cell culture study
Raziskava o celičnih kulturah
Information on short-term toxicity and pathogenicity
Informacije o kratkoročni toksičnosti in patogenosti
Health effects after repeated inhalatory exposure
Vplivi na zdravje po ponovljeni izpostavljenosti vdihavanju
Proposed treatment: first aid measures, medical treatment
Predlagano ravnanje: ukrepi prve pomoči, zdravljenje
Any pathogenicity and infectiveness to humans and other mammals under conditions of immunosuppression
Patogenost in infektivnost za ljudi in druge sesalce pri imunosupresiji
END OF TIER I
KONEC STOPNJE I
TIER II
STOPNJA II
Specific toxicity, pathogenicity and infectiveness studies
Posebne raziskave o toksičnosti, patogenosti in kužnosti
Genotoxicity — In vivo studies in somatic cells
Genotoksičnost – raziskave in vivo na somatskih celicah
Genotoxicity — In vivo studies in germ cells
Genotoksičnost – raziskave in vivo na kličnih celicah
END OF TIER II
KONEC STOPNJE II
Summary of mammalian toxicity, pathogenicity and infectiveness and overall evaluation
Povzetek toksičnosti, patogenosti in kužnosti pri sesalcih in splošna ocena
RESIDUES IN OR ON TREATED MATERIALS, FOOD AND FEED
OSTANKI V ALI NA TRETIRANIH PROIZVODIH, ŽIVILIH IN KRMI
Persistence and likelihood of multiplication in or on treated materials, feedingstuffs or foodstuffs
Obstojnost in verjetnost razmnoževanja v ali na tretiranih materialih, krmi ali živilih
Further information required
Dodatne zahtevane informacije
Non-viable residues
Neživi ostanki
Viable residues
Živi ostanki
Summary and evaluation of residues in or on treated materials, food and feed
Povzetek in ocena ostankov v ali na tretiranih snoveh, hrani in krmi
FATE AND BEHAVIOUR IN THE ENVIRONMENT
KONČNO STANJE IN OBNAŠANJE V OKOLJU
Persistence and multiplication
Obstojnost in razmnoževanje
Soil
Tla
Mobility
Gibljivost
Summary and evaluation of fate and behaviour in the environment
Povzetek in ocena končnega stanja in obnašanja v okolju
EFFECTS ON NON-TARGET ORGANISMS
VPLIVI NA NECILJNE ORGANIZME
Effects on birds
Vplivi na ptice
Effects on aquatic organisms
Vplivi na vodne organizme
Effects on fish
Vplivi na ribe
Effects on freshwater invertebrates
Vplivi na sladkovodne nevretenčarje
Effects on algae growth
Vplivi na rast alg
Effects on plants other than algae
Vplivi na rastline, razen alg
Effects on bees
Vplivi na čebele
Effects on arthropods other than bees
Vplivi na členonožce, razen čebel
Effects on earthworms
Vplivi na deževnike
Effects on soil micro-organisms
Vplivi na talne mikroorganizme
Further studies
Nadaljnje raziskave
Terrestrial plants
Zemeljske rastline
Mammals
Sesalci
Other relevant species and processes
Druge zadevne vrste in procesi
Summary and evaluation of effects on non-target organisms
Povzetek in ocena vplivov na neciljne organizme
CLASSIFICATION AND LABELLING
RAZVRŠČANJE IN OZNAČEVANJE
The dossier shall be accompanied by a reasoned proposals for allocating an active substance which is a micro-organism to one of the risk groups specified in Article 2 of Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work [1] together with indications on the need for products to carry the biohazard sign specified in Annex II to that Directive.X.
Dokumentaciji je treba priložiti utemeljene predloge za razporeditev aktivne snovi, ki je mikroorganizem, v eno izmed skupin tveganja iz člena 2 direktive 2000/54/ES Evropskega parlamenta in Sveta z dne 18. septembra 2000 o varovanju delavcev pred tveganji zaradi izpostavljenosti biološkim dejavnikom pri delu [1], skupaj z navedbami, ali morajo biti proizvodi označeni z znakom za biološko nevarnost, določenim v Prilogi II k navedeni direktivi.X.
SUMMARY AND EVALUATION OF SECTIONS I TO IX INCLUDING CONCLUSIONS OF THE RISK ASSESSMENT AND RECOMMENDATIONS
POVZETEK IN OCENA ODDELKOV I DO IX, VKLJUČNO Z ZAKLJUČKI OCENE TVEGANJA IN PRIPOROČILI
ANNEX IVB
PRILOGA IVB
DATA SET FOR BIOCIDAL PRODUCTS
PODATKI ZA BIOCIDNE PRIPRAVKE
This Annex provides data requirements for the authorisation of a biocidal product based on preparations of micro-organisms.
Ta priloga predpisuje zahteve glede podatkov za izdajo dovoljenja za biocidni pripravek na podlagi pripravkov iz mikroorganizmov.